MADRIGAL PHARMACEUTICALS, INC. (MDGL) › Operating Cash FlowMADRIGAL PHARMACEUTICALS, INC. (MDGL) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2016: -$17.61M2017: -$22.32M2018: -$25.51M2019: -$41.62M2020: -$157.56M2021: -$183.92M2022: -$224.86M2023: -$324.23M2024: -$455.57M2025: -$189.55M-$189.55M2016Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$189.55M+58.4%2024-$455.57M-40.5%2023-$324.23M-44.2%2022-$224.86M-22.3%2021-$183.92M-16.7%2020-$157.56M-278.5%2019-$41.62M-63.2%2018-$25.51M-14.3%2017-$22.32M-26.7%2016-$17.61M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share